Literature DB >> 11918758

Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis.

Marta Mosca1, Walter Bencivelli, Rossella Neri, Antonio Pasquariello, Valentina Batini, Rodolfo Puccini, Antonio Tavoni, Stefano Bombardieri.   

Abstract

BACKGROUND: Even when treated with current protocols, 25 to 30% of systemic lupus erythematosus (SLE) patients with diffuse proliferative glomerulonephritis (DPGN) evolve to end-stage renal disease (ESRD). The occurrence of renal flares is considered to be an important risk factor for the evolution to ESRD. The aim of this retrospective study was to evaluate the incidence and prognostic significance of renal flares in SLE patients with DPGN and to identify predictors for the occurrence of flares.
METHODS: Ninety-one SLE patients were selected for study based on the following criteria: (a) evidence of renal involvement, (b) a follow-up of at least 6 months after the renal biopsy, and (c) a steady improvement in renal manifestations after the biopsy lasting for at least three months.
RESULTS: Renal flares occurred in 54% of the patients after renal biopsy and appropriate treatment. A younger age at the time of renal biopsy correlated with the occurrence of renal flares. A high activity index (> or =10) and karyorrhexis on histology correlated with the occurrence of nephritic flares. Twenty-seven percent of the patients developed ESRD. The number of renal flares, nephritic flares, and "early" proteinuric flares (that is, those occurring in the first 18 months after renal biopsy) as well as serum creatinine levels, karyorrhexis, and chronicity index on renal histology were correlated with doubling serum creatinine.
CONCLUSIONS: Our results suggest that (a) a distinct subgroup of SLE patients exists, made up of younger patients with extensive, active lesions on renal biopsy, who are at higher risk for renal flares, (b) renal flares represent important predictors of doubling serum creatinine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918758     DOI: 10.1046/j.1523-1755.2002.00280.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.

Authors:  Juan M Mejia-Vilet; Samir V Parikh; Huijuan Song; Paolo Fadda; John P Shapiro; Isabelle Ayoub; Lianbo Yu; Jianying Zhang; Norma Uribe-Uribe; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

Review 2.  B-cell depletion in the treatment of lupus nephritis.

Authors:  Jon W Gregersen; David R W Jayne
Journal:  Nat Rev Nephrol       Date:  2012-07-17       Impact factor: 28.314

Review 3.  Diagnosis and treatment of lupus nephritis flares--an update.

Authors:  Ben Sprangers; Marianne Monahan; Gerald B Appel
Journal:  Nat Rev Nephrol       Date:  2012-11-13       Impact factor: 28.314

Review 4.  Treatment of proliferative lupus nephritis: a slowly changing landscape.

Authors:  Vladimir Tesar; Zdenka Hruskova
Journal:  Nat Rev Nephrol       Date:  2010-12-21       Impact factor: 28.314

Review 5.  Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications.

Authors:  Natasha Jordan; David D'Cruz
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

6.  An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis.

Authors:  Stacy Ardoin; Daniel J Birmingham; Paul L Hebert; Chack-Yung Yu; Brad H Rovin; Lee A Hebert
Journal:  Arthritis Rheum       Date:  2011-07

7.  Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.

Authors:  Daniel J Birmingham; Brad H Rovin; Ganesh Shidham; Michael Bissell; Haikady N Nagaraja; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-01       Impact factor: 8.237

8.  Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults.

Authors:  Keisha L Gibson; Debbie S Gipson; Susan A Massengill; Mary Anne Dooley; William A Primack; Maria A Ferris; Susan L Hogan
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-09       Impact factor: 8.237

9.  Simultaneous positivity for anti-DNA, anti-nucleosome and anti-histone antibodies is a marker for more severe lupus nephritis.

Authors:  Manshu Sui; Mansu Sui; Qingyuan Lin; Zhaozhen Xu; Xiaojing Han; Rujuan Xie; Xiuzhi Jia; Xiaofang Guo; Weihua Zhang; Xiuru Guan; Huan Ren
Journal:  J Clin Immunol       Date:  2012-10-26       Impact factor: 8.317

10.  Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis.

Authors:  Samir V Parikh; Haikady N Nagaraja; Lee Hebert; Brad H Rovin
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.